CA2907177A1 - Procedes et compositions pour l'evaluation de marqueurs genetiques - Google Patents

Procedes et compositions pour l'evaluation de marqueurs genetiques

Info

Publication number: CA2907177A1
Authority: CA; Canada
Prior art keywords: nucleic acid; sequence; target; capture; probes
Prior art date: 2013-03-15
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA2907177A

Other languages

English (en)

Inventor

Gregory Porreca

Mark UMBARGER

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Good Start Genetics Inc

Original Assignee

Good Start Genetics Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-03-15

Filing date

2014-03-14

Publication date

2014-09-18

2013-07-02 Priority claimed from US13/934,093 external-priority patent/US12129514B2/en

2014-03-14 Application filed by Good Start Genetics Inc filed Critical Good Start Genetics Inc

2014-09-18 Publication of CA2907177A1 publication Critical patent/CA2907177A1/fr

Status Abandoned legal-status Critical Current

Links

238000000034 method Methods 0.000 title claims abstract description 283
230000002068 genetic effect Effects 0.000 title abstract description 88
239000000203 mixture Substances 0.000 title abstract description 40
150000007523 nucleic acids Chemical group 0.000 claims abstract description 468
239000000523 sample Substances 0.000 claims description 501
102000039446 nucleic acids Human genes 0.000 claims description 434
108020004707 nucleic acids Proteins 0.000 claims description 434
230000008685 targeting Effects 0.000 claims description 122
230000003321 amplification Effects 0.000 claims description 93
238000003199 nucleic acid amplification method Methods 0.000 claims description 93
108010079245 Cystic Fibrosis Transmembrane Conductance Regulator Proteins 0.000 claims description 88
102100022548 Beta-hexosaminidase subunit alpha Human genes 0.000 claims description 58
108090000623 proteins and genes Proteins 0.000 claims description 55
239000002773 nucleotide Substances 0.000 claims description 39
125000003729 nucleotide group Chemical group 0.000 claims description 37
230000000295 complement effect Effects 0.000 claims description 31
102100039246 Elongator complex protein 1 Human genes 0.000 claims description 16
101000785978 Homo sapiens Sphingomyelin phosphodiesterase Proteins 0.000 claims description 16
102100026263 Sphingomyelin phosphodiesterase Human genes 0.000 claims description 16
102100024645 ATP-binding cassette sub-family C member 8 Human genes 0.000 claims description 14
101000813117 Homo sapiens Elongator complex protein 1 Proteins 0.000 claims description 14
101000760570 Homo sapiens ATP-binding cassette sub-family C member 8 Proteins 0.000 claims description 13
238000012216 screening Methods 0.000 claims description 12
102100026502 Mucolipin-1 Human genes 0.000 claims description 10
108090000765 processed proteins & peptides Proteins 0.000 claims description 10
102100035352 2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial Human genes 0.000 claims description 9
108091026890 Coding region Proteins 0.000 claims description 9
201000003883 Cystic fibrosis Diseases 0.000 claims description 9
102100036382 Protocadherin-15 Human genes 0.000 claims description 9
229920001184 polypeptide Polymers 0.000 claims description 9
102000004196 processed proteins & peptides Human genes 0.000 claims description 9
102100023419 Cystic fibrosis transmembrane conductance regulator Human genes 0.000 claims description 8
101001072259 Homo sapiens Protocadherin-15 Proteins 0.000 claims description 8
102100035315 2-oxoisovalerate dehydrogenase subunit beta, mitochondrial Human genes 0.000 claims description 7
208000005692 Bloom Syndrome Diseases 0.000 claims description 7
101000597680 Homo sapiens 2-oxoisovalerate dehydrogenase subunit beta, mitochondrial Proteins 0.000 claims description 7
208000022526 Canavan disease Diseases 0.000 claims description 6
206010053138 Congenital aplastic anaemia Diseases 0.000 claims description 6
201000004939 Fanconi anemia Diseases 0.000 claims description 6
208000024393 maple syrup urine disease Diseases 0.000 claims description 6
102100031060 Clarin-1 Human genes 0.000 claims description 5
208000026350 Inborn Genetic disease Diseases 0.000 claims description 5
208000001730 Familial dysautonomia Diseases 0.000 claims description 4
208000030162 Maple syrup disease Diseases 0.000 claims description 4
208000008955 Mucolipidoses Diseases 0.000 claims description 4
201000001638 Riley-Day syndrome Diseases 0.000 claims description 4
208000022292 Tay-Sachs disease Diseases 0.000 claims description 4
208000016361 genetic disease Diseases 0.000 claims description 4
101710177818 2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial Proteins 0.000 claims description 3
108700023155 Aspartoacylases Proteins 0.000 claims description 3
208000000454 Congenital Hyperinsulinism Diseases 0.000 claims description 3
102000028526 Dihydrolipoamide Dehydrogenase Human genes 0.000 claims description 3
108010028127 Dihydrolipoamide Dehydrogenase Proteins 0.000 claims description 3
208000033961 familial 2 hyperinsulinemic hypoglycemia Diseases 0.000 claims description 3
208000011532 familial hyperinsulinism Diseases 0.000 claims description 3
208000007345 glycogen storage disease Diseases 0.000 claims description 3
102100027447 ATP-dependent DNA helicase Q1 Human genes 0.000 claims description 2
101710167754 Elongator complex protein 1 Proteins 0.000 claims description 2
102000003638 Glucose-6-Phosphatase Human genes 0.000 claims description 2
108010086800 Glucose-6-Phosphatase Proteins 0.000 claims description 2
108010053317 Hexosaminidase A Proteins 0.000 claims description 2
102000016871 Hexosaminidase A Human genes 0.000 claims description 2
101000580659 Homo sapiens ATP-dependent DNA helicase Q1 Proteins 0.000 claims description 2
101001045440 Homo sapiens Beta-hexosaminidase subunit alpha Proteins 0.000 claims description 2
208000024867 Pyruvate dehydrogenase E3 deficiency Diseases 0.000 claims description 2
208000014769 Usher Syndromes Diseases 0.000 claims description 2
230000003197 catalytic effect Effects 0.000 claims description 2
101710093463 Clarin-1 Proteins 0.000 claims 2
102000018919 aspartoacylase Human genes 0.000 claims 2
201000011240 Frontotemporal dementia Diseases 0.000 claims 1
208000000609 Pick Disease of the Brain Diseases 0.000 claims 1
208000024571 Pick disease Diseases 0.000 claims 1
201000007769 mucolipidosis Diseases 0.000 claims 1
238000004458 analytical method Methods 0.000 abstract description 65
108091028043 Nucleic acid sequence Proteins 0.000 abstract description 19
238000012300 Sequence Analysis Methods 0.000 abstract description 8
210000004027 cell Anatomy 0.000 description 213
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 133
238000012163 sequencing technique Methods 0.000 description 120
201000010099 disease Diseases 0.000 description 115
230000035772 mutation Effects 0.000 description 102
238000006243 chemical reaction Methods 0.000 description 97
108700028369 Alleles Proteins 0.000 description 92
102000008371 intracellularly ATP-gated chloride channel activity proteins Human genes 0.000 description 86
238000007481 next generation sequencing Methods 0.000 description 74
238000002360 preparation method Methods 0.000 description 74
210000004369 blood Anatomy 0.000 description 70
239000008280 blood Substances 0.000 description 70
239000002585 base Substances 0.000 description 68
238000009396 hybridization Methods 0.000 description 67
238000012217 deletion Methods 0.000 description 66
230000037430 deletion Effects 0.000 description 66
108020004414 DNA Proteins 0.000 description 65
238000001514 detection method Methods 0.000 description 65
238000003780 insertion Methods 0.000 description 61
230000037431 insertion Effects 0.000 description 61
239000013615 primer Substances 0.000 description 53
239000000047 product Substances 0.000 description 53
102100032948 Aspartoacylase Human genes 0.000 description 52
101000797251 Homo sapiens Aspartoacylase Proteins 0.000 description 51
238000003205 genotyping method Methods 0.000 description 44
238000003556 assay Methods 0.000 description 42
239000012472 biological sample Substances 0.000 description 42
230000035945 sensitivity Effects 0.000 description 35
101000997662 Homo sapiens Lysosomal acid glucosylceramidase Proteins 0.000 description 31
102100033342 Lysosomal acid glucosylceramidase Human genes 0.000 description 31
230000000670 limiting effect Effects 0.000 description 31
238000004422 calculation algorithm Methods 0.000 description 26
238000013459 approach Methods 0.000 description 25
102000054765 polymorphisms of proteins Human genes 0.000 description 24
239000000872 buffer Substances 0.000 description 21
230000001965 increasing effect Effects 0.000 description 21
108091093037 Peptide nucleic acid Proteins 0.000 description 20
239000013610 patient sample Substances 0.000 description 20
230000009897 systematic effect Effects 0.000 description 20
230000000875 corresponding effect Effects 0.000 description 18
208000035475 disorder Diseases 0.000 description 18
239000012634 fragment Substances 0.000 description 18
210000000349 chromosome Anatomy 0.000 description 16
238000005516 engineering process Methods 0.000 description 16
238000004088 simulation Methods 0.000 description 16
230000003252 repetitive effect Effects 0.000 description 15
108091093088 Amplicon Proteins 0.000 description 14
102100031470 Homeobox protein ARX Human genes 0.000 description 14
101000923090 Homo sapiens Homeobox protein ARX Proteins 0.000 description 14
230000015572 biosynthetic process Effects 0.000 description 14
238000009826 distribution Methods 0.000 description 14
230000008569 process Effects 0.000 description 14
238000006467 substitution reaction Methods 0.000 description 14
238000003786 synthesis reaction Methods 0.000 description 14
108010063905 Ampligase Proteins 0.000 description 13
206010028980 Neoplasm Diseases 0.000 description 13
230000002159 abnormal effect Effects 0.000 description 13
238000013461 design Methods 0.000 description 13
102100035631 Bloom syndrome protein Human genes 0.000 description 12
108060002716 Exonuclease Proteins 0.000 description 12
102000013165 exonuclease Human genes 0.000 description 12
238000012252 genetic analysis Methods 0.000 description 12
239000011541 reaction mixture Substances 0.000 description 12
238000010008 shearing Methods 0.000 description 12
238000012360 testing method Methods 0.000 description 12
230000000694 effects Effects 0.000 description 11
238000002955 isolation Methods 0.000 description 11
108091009167 Bloom syndrome protein Proteins 0.000 description 10
102100023319 Dihydrolipoyl dehydrogenase, mitochondrial Human genes 0.000 description 10
230000007423 decrease Effects 0.000 description 10
108010007577 Exodeoxyribonuclease I Proteins 0.000 description 9
102100029075 Exonuclease 1 Human genes 0.000 description 9
102100040748 Polyglutamine-binding protein 1 Human genes 0.000 description 9
230000003902 lesion Effects 0.000 description 9
230000001717 pathogenic effect Effects 0.000 description 9
101000611427 Homo sapiens Polyglutamine-binding protein 1 Proteins 0.000 description 8
102100021947 Survival motor neuron protein Human genes 0.000 description 8
UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 8
238000012544 monitoring process Methods 0.000 description 8
230000001850 reproductive effect Effects 0.000 description 8
238000005070 sampling Methods 0.000 description 8
210000001519 tissue Anatomy 0.000 description 8
108091032973 (ribonucleotides)n+m Proteins 0.000 description 7
102000053602 DNA Human genes 0.000 description 7
108700024394 Exon Proteins 0.000 description 7
102100033495 Glycine dehydrogenase (decarboxylating), mitochondrial Human genes 0.000 description 7
102100037931 Harmonin Human genes 0.000 description 7
101000805947 Homo sapiens Harmonin Proteins 0.000 description 7
101000611731 Homo sapiens Putative tRNA (cytidine(32)/guanosine(34)-2'-O)-methyltransferase Proteins 0.000 description 7
101000617738 Homo sapiens Survival motor neuron protein Proteins 0.000 description 7
101000612838 Homo sapiens Tetraspanin-7 Proteins 0.000 description 7
101150091161 MCOLN1 gene Proteins 0.000 description 7
108091034117 Oligonucleotide Proteins 0.000 description 7
102100025516 Peroxisome biogenesis factor 2 Human genes 0.000 description 7
102100040688 Putative tRNA (cytidine(32)/guanosine(34)-2'-O)-methyltransferase Human genes 0.000 description 7
102100040952 Tetraspanin-7 Human genes 0.000 description 7
102100023931 Transcriptional regulator ATRX Human genes 0.000 description 7
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 7
238000010348 incorporation Methods 0.000 description 7
239000000463 material Substances 0.000 description 7
230000000858 peroxisomal effect Effects 0.000 description 7
238000007480 sanger sequencing Methods 0.000 description 7
238000011144 upstream manufacturing Methods 0.000 description 7
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 6
102100022509 Cadherin-23 Human genes 0.000 description 6
101710088194 Dehydrogenase Proteins 0.000 description 6
102100022263 Disks large homolog 3 Human genes 0.000 description 6
102100036264 Glucose-6-phosphatase catalytic subunit 1 Human genes 0.000 description 6
101000597665 Homo sapiens 2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial Proteins 0.000 description 6
101000907783 Homo sapiens Cystic fibrosis transmembrane conductance regulator Proteins 0.000 description 6
101000930910 Homo sapiens Glucose-6-phosphatase catalytic subunit 1 Proteins 0.000 description 6
101000998096 Homo sapiens Glycine dehydrogenase (decarboxylating), mitochondrial Proteins 0.000 description 6
101000780208 Homo sapiens Long-chain-fatty-acid-CoA ligase 4 Proteins 0.000 description 6
101000861263 Homo sapiens Steroid 21-hydroxylase Proteins 0.000 description 6
102100034319 Long-chain-fatty-acid-CoA ligase 4 Human genes 0.000 description 6
108091081062 Repeated sequence (DNA) Proteins 0.000 description 6
102100027545 Steroid 21-hydroxylase Human genes 0.000 description 6
102100036860 Troponin T, slow skeletal muscle Human genes 0.000 description 6
239000002253 acid Substances 0.000 description 6
230000008436 biogenesis Effects 0.000 description 6
201000011510 cancer Diseases 0.000 description 6
239000007795 chemical reaction product Substances 0.000 description 6
230000001351 cycling effect Effects 0.000 description 6
OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 6
238000002405 diagnostic procedure Methods 0.000 description 6
229940079920 digestives acid preparations Drugs 0.000 description 6
230000002255 enzymatic effect Effects 0.000 description 6
238000005259 measurement Methods 0.000 description 6
-1 methylmalonyl Chemical group 0.000 description 6
230000004048 modification Effects 0.000 description 6
238000012986 modification Methods 0.000 description 6
230000004044 response Effects 0.000 description 6
230000002441 reversible effect Effects 0.000 description 6
102220204140 rs376084231 Human genes 0.000 description 6
235000000346 sugar Nutrition 0.000 description 6
208000005443 Circulating Neoplastic Cells Diseases 0.000 description 5
102000018825 Fanconi Anemia Complementation Group C protein Human genes 0.000 description 5
108010027673 Fanconi Anemia Complementation Group C protein Proteins 0.000 description 5
102100037156 Gap junction beta-2 protein Human genes 0.000 description 5
101000828537 Homo sapiens Synaptic functional regulator FMR1 Proteins 0.000 description 5
102000003624 MCOLN1 Human genes 0.000 description 5
102100024590 Medium-chain specific acyl-CoA dehydrogenase, mitochondrial Human genes 0.000 description 5
108091092878 Microsatellite Proteins 0.000 description 5
102100036598 Peroxisomal targeting signal 1 receptor Human genes 0.000 description 5
102100036197 Prosaposin Human genes 0.000 description 5
102100023532 Synaptic functional regulator FMR1 Human genes 0.000 description 5
102100033080 Tropomyosin alpha-3 chain Human genes 0.000 description 5
102100031835 Unconventional myosin-VIIa Human genes 0.000 description 5
238000005903 acid hydrolysis reaction Methods 0.000 description 5
230000008901 benefit Effects 0.000 description 5
230000008859 change Effects 0.000 description 5
238000009223 counseling Methods 0.000 description 5
238000011156 evaluation Methods 0.000 description 5
108010052305 exodeoxyribonuclease III Proteins 0.000 description 5
238000010438 heat treatment Methods 0.000 description 5
238000011534 incubation Methods 0.000 description 5
238000004393 prognosis Methods 0.000 description 5
238000012552 review Methods 0.000 description 5
238000011282 treatment Methods 0.000 description 5
108091028732 Concatemer Proteins 0.000 description 4
238000001712 DNA sequencing Methods 0.000 description 4
102100022317 Dihydropteridine reductase Human genes 0.000 description 4
208000001914 Fragile X syndrome Diseases 0.000 description 4
102100037777 Galactokinase Human genes 0.000 description 4
102100021519 Hemoglobin subunit beta Human genes 0.000 description 4
101000899442 Homo sapiens Cadherin-23 Proteins 0.000 description 4
101000902100 Homo sapiens Disks large homolog 3 Proteins 0.000 description 4
101000954092 Homo sapiens Gap junction beta-2 protein Proteins 0.000 description 4
101000899111 Homo sapiens Hemoglobin subunit beta Proteins 0.000 description 4
101001088887 Homo sapiens Lysine-specific demethylase 5C Proteins 0.000 description 4
101000760730 Homo sapiens Medium-chain specific acyl-CoA dehydrogenase, mitochondrial Proteins 0.000 description 4
101001114654 Homo sapiens Methylmalonic aciduria type A protein, mitochondrial Proteins 0.000 description 4
101000850794 Homo sapiens Tropomyosin alpha-3 chain Proteins 0.000 description 4
101000851357 Homo sapiens Troponin T, slow skeletal muscle Proteins 0.000 description 4
101001128468 Homo sapiens Unconventional myosin-VIIa Proteins 0.000 description 4
102000003960 Ligases Human genes 0.000 description 4
108090000364 Ligases Proteins 0.000 description 4
102100033249 Lysine-specific demethylase 5C Human genes 0.000 description 4
208000024556 Mendelian disease Diseases 0.000 description 4
102100023377 Methylmalonic aciduria type A protein, mitochondrial Human genes 0.000 description 4
102100034434 Nebulin Human genes 0.000 description 4
108020005187 Oligonucleotide Probes Proteins 0.000 description 4
102100035592 Oligophrenin-1 Human genes 0.000 description 4
102100032931 Peroxisome assembly factor 2 Human genes 0.000 description 4
108020004682 Single-Stranded DNA Proteins 0.000 description 4
239000007983 Tris buffer Substances 0.000 description 4
ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 4
208000010206 X-Linked Mental Retardation Diseases 0.000 description 4
102100024669 Zinc finger protein 41 Human genes 0.000 description 4
150000001413 amino acids Chemical group 0.000 description 4
208000036878 aneuploidy Diseases 0.000 description 4
239000003795 chemical substances by application Substances 0.000 description 4
239000005516 coenzyme A Substances 0.000 description 4
229940093530 coenzyme a Drugs 0.000 description 4
238000010276 construction Methods 0.000 description 4
238000007405 data analysis Methods 0.000 description 4
230000003247 decreasing effect Effects 0.000 description 4
230000001419 dependent effect Effects 0.000 description 4
238000002474 experimental method Methods 0.000 description 4
238000002844 melting Methods 0.000 description 4
230000008018 melting Effects 0.000 description 4
201000003694 methylmalonic acidemia Diseases 0.000 description 4
239000002751 oligonucleotide probe Substances 0.000 description 4
229920000155 polyglutamine Polymers 0.000 description 4
238000003752 polymerase chain reaction Methods 0.000 description 4
102000040430 polynucleotide Human genes 0.000 description 4
108091033319 polynucleotide Proteins 0.000 description 4
239000002157 polynucleotide Substances 0.000 description 4
239000011535 reaction buffer Substances 0.000 description 4
230000008080 stochastic effect Effects 0.000 description 4
238000003860 storage Methods 0.000 description 4
208000031906 susceptibility to X-linked 2 autism Diseases 0.000 description 4
208000011580 syndromic disease Diseases 0.000 description 4
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 4
238000010200 validation analysis Methods 0.000 description 4
102100036512 7-dehydrocholesterol reductase Human genes 0.000 description 3
102100026656 Actin, alpha skeletal muscle Human genes 0.000 description 3
102100039338 Aminomethyltransferase, mitochondrial Human genes 0.000 description 3
102100020999 Argininosuccinate synthase Human genes 0.000 description 3
102100022146 Arylsulfatase A Human genes 0.000 description 3
206010003591 Ataxia Diseases 0.000 description 3
102000007371 Ataxin-3 Human genes 0.000 description 3
102100033743 Biotin-[acetyl-CoA-carboxylase] ligase Human genes 0.000 description 3
108020004705 Codon Proteins 0.000 description 3
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
102100028603 Glutaryl-CoA dehydrogenase, mitochondrial Human genes 0.000 description 3
101000928720 Homo sapiens 7-dehydrocholesterol reductase Proteins 0.000 description 3
101000834207 Homo sapiens Actin, alpha skeletal muscle Proteins 0.000 description 3
101000784014 Homo sapiens Argininosuccinate synthase Proteins 0.000 description 3
101000992973 Homo sapiens Clarin-1 Proteins 0.000 description 3
101000902365 Homo sapiens Dihydropteridine reductase Proteins 0.000 description 3
101001024874 Homo sapiens Galactokinase Proteins 0.000 description 3
101000995272 Homo sapiens Nebulin Proteins 0.000 description 3
101001137060 Homo sapiens Oligophrenin-1 Proteins 0.000 description 3
101001073025 Homo sapiens Peroxisomal targeting signal 1 receptor Proteins 0.000 description 3
101000730779 Homo sapiens Peroxisome assembly factor 2 Proteins 0.000 description 3
101001099372 Homo sapiens Peroxisome biogenesis factor 1 Proteins 0.000 description 3
101000693847 Homo sapiens Peroxisome biogenesis factor 2 Proteins 0.000 description 3
101000904868 Homo sapiens Transcriptional regulator ATRX Proteins 0.000 description 3
101000819146 Homo sapiens UDP-glucose 4-epimerase Proteins 0.000 description 3
101000760181 Homo sapiens Zinc finger protein 41 Proteins 0.000 description 3
102100027064 Lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mitochondrial Human genes 0.000 description 3
206010059521 Methylmalonic aciduria Diseases 0.000 description 3
206010072930 Mucolipidosis type IV Diseases 0.000 description 3
102100028224 Peroxisome assembly protein 12 Human genes 0.000 description 3
102100038881 Peroxisome biogenesis factor 1 Human genes 0.000 description 3
201000011252 Phenylketonuria Diseases 0.000 description 3
102100024639 Short-chain specific acyl-CoA dehydrogenase, mitochondrial Human genes 0.000 description 3
201000003629 Spinocerebellar ataxia type 8 Diseases 0.000 description 3
102100021436 UDP-glucose 4-epimerase Human genes 0.000 description 3
201000008572 Usher syndrome type 1F Diseases 0.000 description 3
102100037929 Usher syndrome type-1G protein Human genes 0.000 description 3
210000001766 X chromosome Anatomy 0.000 description 3
210000004381 amniotic fluid Anatomy 0.000 description 3
208000034084 autosomal dominant nonsyndromic hearing loss 3A Diseases 0.000 description 3
229960002685 biotin Drugs 0.000 description 3
235000020958 biotin Nutrition 0.000 description 3
239000011616 biotin Substances 0.000 description 3
210000002459 blastocyst Anatomy 0.000 description 3
238000011088 calibration curve Methods 0.000 description 3
239000000969 carrier Substances 0.000 description 3
210000004252 chorionic villi Anatomy 0.000 description 3
235000019506 cigar Nutrition 0.000 description 3
239000013068 control sample Substances 0.000 description 3
230000002596 correlated effect Effects 0.000 description 3
229940104302 cytosine Drugs 0.000 description 3
229940079593 drug Drugs 0.000 description 3
239000003814 drug Substances 0.000 description 3
230000002708 enhancing effect Effects 0.000 description 3
238000000605 extraction Methods 0.000 description 3
230000001605 fetal effect Effects 0.000 description 3
238000013467 fragmentation Methods 0.000 description 3
238000006062 fragmentation reaction Methods 0.000 description 3
230000006870 function Effects 0.000 description 3
238000002513 implantation Methods 0.000 description 3
235000019689 luncheon sausage Nutrition 0.000 description 3
239000000178 monomer Substances 0.000 description 3
238000002887 multiple sequence alignment Methods 0.000 description 3
238000007837 multiplex assay Methods 0.000 description 3
239000006199 nebulizer Substances 0.000 description 3
238000002515 oligonucleotide synthesis Methods 0.000 description 3
150000007530 organic bases Chemical class 0.000 description 3
244000052769 pathogen Species 0.000 description 3
230000009984 peri-natal effect Effects 0.000 description 3
230000037452 priming Effects 0.000 description 3
102000004169 proteins and genes Human genes 0.000 description 3
230000002829 reductive effect Effects 0.000 description 3
102200132384 rs28940279 Human genes 0.000 description 3
208000001392 short chain acyl-CoA dehydrogenase deficiency Diseases 0.000 description 3
241000894007 species Species 0.000 description 3
150000008163 sugars Chemical class 0.000 description 3
208000002670 vitamin B12 deficiency Diseases 0.000 description 3
MXCVHSXCXPHOLP-UHFFFAOYSA-N 4-oxo-6-propylchromene-2-carboxylic acid Chemical compound O1C(C(O)=O)=CC(=O)C2=CC(CCC)=CC=C21 MXCVHSXCXPHOLP-UHFFFAOYSA-N 0.000 description 2
KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
102100024378 AF4/FMR2 family member 2 Human genes 0.000 description 2
GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
229930024421 Adenine Natural products 0.000 description 2
241000115929 Anabolia appendix Species 0.000 description 2
108010032947 Ataxin-3 Proteins 0.000 description 2
241000271566 Aves Species 0.000 description 2
102100026044 Biotinidase Human genes 0.000 description 2
206010008025 Cerebellar ataxia Diseases 0.000 description 2
108091006146 Channels Proteins 0.000 description 2
208000034030 Chronic neurovisceral acid sphingomyelinase deficiency Diseases 0.000 description 2
102100023376 Corrinoid adenosyltransferase Human genes 0.000 description 2
241000938605 Crocodylia Species 0.000 description 2
238000007400 DNA extraction Methods 0.000 description 2
239000003155 DNA primer Substances 0.000 description 2
201000008163 Dentatorubral pallidoluysian atrophy Diseases 0.000 description 2
101710185762 Disks large homolog 3 Proteins 0.000 description 2
102000004190 Enzymes Human genes 0.000 description 2
108090000790 Enzymes Proteins 0.000 description 2
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
208000027472 Galactosemias Diseases 0.000 description 2
208000015872 Gaucher disease Diseases 0.000 description 2
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
241000282412 Homo Species 0.000 description 2
101000833172 Homo sapiens AF4/FMR2 family member 2 Proteins 0.000 description 2
101000871771 Homo sapiens Biotin-[acetyl-CoA-carboxylase] ligase Proteins 0.000 description 2
101000803270 Homo sapiens Bloom syndrome protein Proteins 0.000 description 2
101100494478 Homo sapiens CDH23 gene Proteins 0.000 description 2
101001114650 Homo sapiens Corrinoid adenosyltransferase Proteins 0.000 description 2
101001058943 Homo sapiens Glutaryl-CoA dehydrogenase, mitochondrial Proteins 0.000 description 2
101100344648 Homo sapiens MCOLN1 gene Proteins 0.000 description 2
101000579342 Homo sapiens Peroxisome assembly protein 12 Proteins 0.000 description 2
101001116682 Homo sapiens Peroxisome assembly protein 26 Proteins 0.000 description 2
101001126498 Homo sapiens Peroxisome biogenesis factor 10 Proteins 0.000 description 2
101001092930 Homo sapiens Prosaposin Proteins 0.000 description 2
101000915806 Homo sapiens Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform Proteins 0.000 description 2
101000760716 Homo sapiens Short-chain specific acyl-CoA dehydrogenase, mitochondrial Proteins 0.000 description 2
206010020365 Homocystinuria Diseases 0.000 description 2
208000023105 Huntington disease Diseases 0.000 description 2
108091092195 Intron Proteins 0.000 description 2
229930194542 Keto Natural products 0.000 description 2
208000002569 Machado-Joseph Disease Diseases 0.000 description 2
TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
241000124008 Mammalia Species 0.000 description 2
201000011442 Metachromatic leukodystrophy Diseases 0.000 description 2
208000032818 Microsatellite Instability Diseases 0.000 description 2
208000018909 Neonatal adrenoleukodystrophy Diseases 0.000 description 2
208000035544 Nonketotic hyperglycinaemia Diseases 0.000 description 2
229910019142 PO4 Inorganic materials 0.000 description 2
101710101427 Peroxisomal targeting signal 1 receptor Proteins 0.000 description 2
102100024925 Peroxisome assembly protein 26 Human genes 0.000 description 2
102100030554 Peroxisome biogenesis factor 10 Human genes 0.000 description 2
108010007100 Pulmonary Surfactant-Associated Protein A Proteins 0.000 description 2
238000003559 RNA-seq method Methods 0.000 description 2
PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 2
102100029014 Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform Human genes 0.000 description 2
201000007410 Smith-Lemli-Opitz syndrome Diseases 0.000 description 2
102100023153 Sodium- and chloride-dependent creatine transporter 1 Human genes 0.000 description 2
208000009415 Spinocerebellar Ataxias Diseases 0.000 description 2
208000036834 Spinocerebellar ataxia type 3 Diseases 0.000 description 2
108010090804 Streptavidin Proteins 0.000 description 2
IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
201000008554 Usher syndrome type 3A Diseases 0.000 description 2
241000251539 Vertebrata <Metazoa> Species 0.000 description 2
101710088929 Voltage-dependent L-type calcium channel subunit alpha-1S Proteins 0.000 description 2
108700042462 X-linked Nuclear Proteins 0.000 description 2
229960000643 adenine Drugs 0.000 description 2
HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 2
230000003322 aneuploid effect Effects 0.000 description 2
210000004436 artificial bacterial chromosome Anatomy 0.000 description 2
210000001106 artificial yeast chromosome Anatomy 0.000 description 2
230000001174 ascending effect Effects 0.000 description 2
230000000712 assembly Effects 0.000 description 2
238000000429 assembly Methods 0.000 description 2
208000031514 autosomal recessive nonsyndromic hearing loss 1A Diseases 0.000 description 2
230000001580 bacterial effect Effects 0.000 description 2
238000001369 bisulfite sequencing Methods 0.000 description 2
238000009395 breeding Methods 0.000 description 2
230000001488 breeding effect Effects 0.000 description 2
239000007853 buffer solution Substances 0.000 description 2
239000003153 chemical reaction reagent Substances 0.000 description 2
208000016617 citrullinemia type I Diseases 0.000 description 2
239000002299 complementary DNA Substances 0.000 description 2
238000004590 computer program Methods 0.000 description 2
238000012790 confirmation Methods 0.000 description 2
238000011109 contamination Methods 0.000 description 2
238000012937 correction Methods 0.000 description 2
CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
238000002790 cross-validation Methods 0.000 description 2
230000001186 cumulative effect Effects 0.000 description 2
230000007812 deficiency Effects 0.000 description 2
238000003745 diagnosis Methods 0.000 description 2
238000010586 diagram Methods 0.000 description 2
230000029087 digestion Effects 0.000 description 2
VLYUGYAKYZETRF-UHFFFAOYSA-N dihydrolipoamide Chemical compound NC(=O)CCCCC(S)CCS VLYUGYAKYZETRF-UHFFFAOYSA-N 0.000 description 2
230000008030 elimination Effects 0.000 description 2
238000003379 elimination reaction Methods 0.000 description 2
230000007613 environmental effect Effects 0.000 description 2
244000000015 environmental pathogen Species 0.000 description 2
238000006911 enzymatic reaction Methods 0.000 description 2
230000037433 frameshift Effects 0.000 description 2
230000014509 gene expression Effects 0.000 description 2
238000013412 genome amplification Methods 0.000 description 2
210000004602 germ cell Anatomy 0.000 description 2
201000011205 glycine encephalopathy Diseases 0.000 description 2
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
239000010931 gold Substances 0.000 description 2
229910052737 gold Inorganic materials 0.000 description 2
238000006460 hydrolysis reaction Methods 0.000 description 2
FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
230000003100 immobilizing effect Effects 0.000 description 2
238000007689 inspection Methods 0.000 description 2
238000009830 intercalation Methods 0.000 description 2
125000000468 ketone group Chemical group 0.000 description 2
238000007834 ligase chain reaction Methods 0.000 description 2
125000005647 linker group Chemical group 0.000 description 2
238000004519 manufacturing process Methods 0.000 description 2
238000013507 mapping Methods 0.000 description 2
230000001404 mediated effect Effects 0.000 description 2
208000005548 medium chain acyl-CoA dehydrogenase deficiency Diseases 0.000 description 2
230000011987 methylation Effects 0.000 description 2
238000007069 methylation reaction Methods 0.000 description 2
239000011325 microbead Substances 0.000 description 2
208000008315 nemaline myopathy 2 Diseases 0.000 description 2
208000024022 non-syndromic X-linked intellectual disability 63 Diseases 0.000 description 2
208000023870 non-syndromic X-linked intellectual disability 9 Diseases 0.000 description 2
201000006790 nonsyndromic deafness Diseases 0.000 description 2
238000005192 partition Methods 0.000 description 2
239000010452 phosphate Substances 0.000 description 2
125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 2
150000004713 phosphodiesters Chemical class 0.000 description 2
108010040003 polyglutamine Proteins 0.000 description 2
QAQREVBBADEHPA-IEXPHMLFSA-N propionyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CC)O[C@H]1N1C2=NC=NC(N)=C2N=C1 QAQREVBBADEHPA-IEXPHMLFSA-N 0.000 description 2
208000022074 proximal spinal muscular atrophy Diseases 0.000 description 2
238000000746 purification Methods 0.000 description 2
238000011002 quantification Methods 0.000 description 2
238000011160 research Methods 0.000 description 2
230000004043 responsiveness Effects 0.000 description 2
238000005096 rolling process Methods 0.000 description 2
102220002720 rs113993959 Human genes 0.000 description 2
102200128201 rs121909011 Human genes 0.000 description 2
102200018999 rs137852870 Human genes 0.000 description 2
102220001527 rs147324677 Human genes 0.000 description 2
102200132012 rs36210737 Human genes 0.000 description 2
102220338971 rs762679408 Human genes 0.000 description 2
238000011896 sensitive detection Methods 0.000 description 2
238000000926 separation method Methods 0.000 description 2
239000007787 solid Substances 0.000 description 2
239000007790 solid phase Substances 0.000 description 2
239000000243 solution Substances 0.000 description 2
238000011895 specific detection Methods 0.000 description 2
238000001228 spectrum Methods 0.000 description 2
239000000126 substance Substances 0.000 description 2
238000002560 therapeutic procedure Methods 0.000 description 2
RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
229940035893 uracil Drugs 0.000 description 2
MWBWWFOAEOYUST-UHFFFAOYSA-N 2-aminopurine Chemical compound NC1=NC=C2N=CNC2=N1 MWBWWFOAEOYUST-UHFFFAOYSA-N 0.000 description 1
ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 1
LRSASMSXMSNRBT-UHFFFAOYSA-N 5-methylcytosine Chemical compound CC1=CNC(=O)N=C1N LRSASMSXMSNRBT-UHFFFAOYSA-N 0.000 description 1
KVDQMARGGBLIJM-UHFFFAOYSA-N 6,7-dihydropteridine Chemical compound N1=CN=CC2=NCCN=C21 KVDQMARGGBLIJM-UHFFFAOYSA-N 0.000 description 1
RYYIULNRIVUMTQ-UHFFFAOYSA-N 6-chloroguanine Chemical compound NC1=NC(Cl)=C2N=CNC2=N1 RYYIULNRIVUMTQ-UHFFFAOYSA-N 0.000 description 1
102100028505 6-pyruvoyl tetrahydrobiopterin synthase Human genes 0.000 description 1
108010045523 6-pyruvoyltetrahydropterin synthase Proteins 0.000 description 1
MSSXOMSJDRHRMC-UHFFFAOYSA-N 9H-purine-2,6-diamine Chemical compound NC1=NC(N)=C2NC=NC2=N1 MSSXOMSJDRHRMC-UHFFFAOYSA-N 0.000 description 1
DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical class CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 1
208000034012 Acid sphingomyelinase deficiency Diseases 0.000 description 1
108010085238 Actins Proteins 0.000 description 1
102000007469 Actins Human genes 0.000 description 1
208000005676 Adrenogenital syndrome Diseases 0.000 description 1
206010067484 Adverse reaction Diseases 0.000 description 1
108010058065 Aminomethyltransferase Proteins 0.000 description 1
102100040141 Aminopeptidase O Human genes 0.000 description 1
101100288434 Arabidopsis thaliana LACS2 gene Proteins 0.000 description 1
101100465385 Arabidopsis thaliana PAF2 gene Proteins 0.000 description 1
102000007372 Ataxin-1 Human genes 0.000 description 1
108010032963 Ataxin-1 Proteins 0.000 description 1
102000007368 Ataxin-7 Human genes 0.000 description 1
108010032953 Ataxin-7 Proteins 0.000 description 1
102000007370 Ataxin2 Human genes 0.000 description 1
108010032951 Ataxin2 Proteins 0.000 description 1
108010078286 Ataxins Proteins 0.000 description 1
102000014461 Ataxins Human genes 0.000 description 1
102100020741 Atrophin-1 Human genes 0.000 description 1
206010003694 Atrophy Diseases 0.000 description 1
101001074429 Bacillus subtilis (strain 168) Polyketide biosynthesis acyltransferase homolog PksD Proteins 0.000 description 1
101000936617 Bacillus velezensis (strain DSM 23117 / BGSC 10A6 / FZB42) Polyketide biosynthesis acyltransferase homolog BaeD Proteins 0.000 description 1
208000035143 Bacterial infection Diseases 0.000 description 1
DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
208000033258 Bifunctional enzyme deficiency Diseases 0.000 description 1
LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
102000014817 CACNA1A Human genes 0.000 description 1
108010052500 Calgranulin A Proteins 0.000 description 1
102000007132 Carboxyl and Carbamoyl Transferases Human genes 0.000 description 1
108010072957 Carboxyl and Carbamoyl Transferases Proteins 0.000 description 1
108010036867 Cerebroside-Sulfatase Proteins 0.000 description 1
RGJOEKWQDUBAIZ-IBOSZNHHSA-N CoASH Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-IBOSZNHHSA-N 0.000 description 1
102000005870 Coenzyme A Ligases Human genes 0.000 description 1
208000008448 Congenital adrenal hyperplasia Diseases 0.000 description 1
208000017870 Congenital fiber-type disproportion myopathy Diseases 0.000 description 1
208000025103 Congenital isolated hyperinsulinism Diseases 0.000 description 1
206010056370 Congestive cardiomyopathy Diseases 0.000 description 1
102000010970 Connexin Human genes 0.000 description 1
108050001175 Connexin Proteins 0.000 description 1
108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 description 1
102000003849 Cytochrome P450 Human genes 0.000 description 1
HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
UCTLRSWJYQTBFZ-UHFFFAOYSA-N Dehydrocholesterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCCC(C)C)CCC33)C)C3=CC=C21 UCTLRSWJYQTBFZ-UHFFFAOYSA-N 0.000 description 1
101710144432 Dihydrolipoyl dehydrogenase, mitochondrial Proteins 0.000 description 1
201000010046 Dilated cardiomyopathy Diseases 0.000 description 1
241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
102100031780 Endonuclease Human genes 0.000 description 1
108010042407 Endonucleases Proteins 0.000 description 1
241000588724 Escherichia coli Species 0.000 description 1
102000000429 Factor XII Human genes 0.000 description 1
108010080865 Factor XII Proteins 0.000 description 1
102100031509 Fibrillin-1 Human genes 0.000 description 1
102000003869 Frataxin Human genes 0.000 description 1
108090000217 Frataxin Proteins 0.000 description 1
108700023157 Galactokinases Proteins 0.000 description 1
108010056771 Glucosidases Proteins 0.000 description 1
102000004366 Glucosidases Human genes 0.000 description 1
108700006770 Glutaric Acidemia I Proteins 0.000 description 1
208000021097 Glutaryl-CoA dehydrogenase deficiency Diseases 0.000 description 1
101710146244 Glutaryl-CoA dehydrogenase, mitochondrial Proteins 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
108010036684 Glycine Dehydrogenase Proteins 0.000 description 1
102100025506 Glycine cleavage system H protein, mitochondrial Human genes 0.000 description 1
101001029059 Homo sapiens ATP-binding cassette sub-family C member 10 Proteins 0.000 description 1
101000889627 Homo sapiens Aminopeptidase O Proteins 0.000 description 1
101000785083 Homo sapiens Atrophin-1 Proteins 0.000 description 1
101000884714 Homo sapiens Beta-defensin 4A Proteins 0.000 description 1
101000855412 Homo sapiens Carbamoyl-phosphate synthase [ammonia], mitochondrial Proteins 0.000 description 1
101000859692 Homo sapiens Cytosolic beta-glucosidase Proteins 0.000 description 1
101100406321 Homo sapiens DBT gene Proteins 0.000 description 1
101100331597 Homo sapiens DLD gene Proteins 0.000 description 1
101000712511 Homo sapiens DNA repair and recombination protein RAD54-like Proteins 0.000 description 1
101000908058 Homo sapiens Dihydrolipoyl dehydrogenase, mitochondrial Proteins 0.000 description 1
101001048716 Homo sapiens ETS domain-containing protein Elk-4 Proteins 0.000 description 1
101000846893 Homo sapiens Fibrillin-1 Proteins 0.000 description 1
101000889125 Homo sapiens Gap junction beta-6 protein Proteins 0.000 description 1
101000856845 Homo sapiens Glycine cleavage system H protein, mitochondrial Proteins 0.000 description 1
101001115426 Homo sapiens MAGUK p55 subfamily member 3 Proteins 0.000 description 1
101000615488 Homo sapiens Methyl-CpG-binding domain protein 2 Proteins 0.000 description 1
101000983292 Homo sapiens N-fatty-acyl-amino acid synthase/hydrolase PM20D1 Proteins 0.000 description 1
101000986595 Homo sapiens Ornithine transcarbamylase, mitochondrial Proteins 0.000 description 1
101100519623 Homo sapiens PEX2 gene Proteins 0.000 description 1
101001074571 Homo sapiens PIN2/TERF1-interacting telomerase inhibitor 1 Proteins 0.000 description 1
101001098982 Homo sapiens Propionyl-CoA carboxylase beta chain, mitochondrial Proteins 0.000 description 1
101000585534 Homo sapiens RNA polymerase II-associated factor 1 homolog Proteins 0.000 description 1
101000684919 Homo sapiens Sodium- and chloride-dependent creatine transporter 1 Proteins 0.000 description 1
101000805943 Homo sapiens Usher syndrome type-1G protein Proteins 0.000 description 1
101000935117 Homo sapiens Voltage-dependent P/Q-type calcium channel subunit alpha-1A Proteins 0.000 description 1
101000868892 Homo sapiens pre-rRNA 2'-O-ribose RNA methyltransferase FTSJ3 Proteins 0.000 description 1
206010020751 Hypersensitivity Diseases 0.000 description 1
UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
229930010555 Inosine Natural products 0.000 description 1
AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
108091080011 Long-chain family Proteins 0.000 description 1
108010011449 Long-chain-fatty-acid-CoA ligase Proteins 0.000 description 1
239000004472 Lysine Substances 0.000 description 1
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
101710192017 Medium-chain specific acyl-CoA dehydrogenase, mitochondrial Proteins 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
102100021299 Methyl-CpG-binding domain protein 2 Human genes 0.000 description 1
108020005196 Mitochondrial DNA Proteins 0.000 description 1
238000000342 Monte Carlo simulation Methods 0.000 description 1
101100013186 Mus musculus Fmr1 gene Proteins 0.000 description 1
108010052185 Myotonin-Protein Kinase Proteins 0.000 description 1
102100022437 Myotonin-protein kinase Human genes 0.000 description 1
KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
UKXVJQOJYPGJQF-UHFFFAOYSA-N N[N].NCC(O)=O Chemical compound N[N].NCC(O)=O UKXVJQOJYPGJQF-UHFFFAOYSA-N 0.000 description 1
208000034965 Nemaline Myopathies Diseases 0.000 description 1
206010061309 Neoplasm progression Diseases 0.000 description 1
101100190845 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) pmp-1 gene Proteins 0.000 description 1
102000005665 Neurotransmitter Transport Proteins Human genes 0.000 description 1
108010084810 Neurotransmitter Transport Proteins Proteins 0.000 description 1
101710147059 Nicking endonuclease Proteins 0.000 description 1
208000014060 Niemann-Pick disease Diseases 0.000 description 1
108020004485 Nonsense Codon Proteins 0.000 description 1
101710163270 Nuclease Proteins 0.000 description 1
108020004711 Nucleic Acid Probes Proteins 0.000 description 1
101710121290 Oligophrenin-1 Proteins 0.000 description 1
108700026244 Open Reading Frames Proteins 0.000 description 1
AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
208000000599 Ornithine Carbamoyltransferase Deficiency Disease Diseases 0.000 description 1
206010052450 Ornithine transcarbamoylase deficiency Diseases 0.000 description 1
208000035903 Ornithine transcarbamylase deficiency Diseases 0.000 description 1
102100028200 Ornithine transcarbamylase, mitochondrial Human genes 0.000 description 1
241000083652 Osca Species 0.000 description 1
238000012408 PCR amplification Methods 0.000 description 1
101150002010 PMP3 gene Proteins 0.000 description 1
206010061902 Pancreatic neoplasm Diseases 0.000 description 1
108010055088 Peroxisomal Biogenesis Factor 2 Proteins 0.000 description 1
101710183599 Peroxisomal targeting signal receptor Proteins 0.000 description 1
101710205272 Peroxisome assembly factor 2 Proteins 0.000 description 1
101710095229 Peroxisome assembly protein 12 Proteins 0.000 description 1
101710124390 Peroxisome biogenesis factor 2 Proteins 0.000 description 1
102100038223 Phenylalanine-4-hydroxylase Human genes 0.000 description 1
108091000080 Phosphotransferase Proteins 0.000 description 1
208000032236 Predisposition to disease Diseases 0.000 description 1
241000932075 Priacanthus hamrur Species 0.000 description 1
101710119292 Probable D-lactate dehydrogenase, mitochondrial Proteins 0.000 description 1
102100039025 Propionyl-CoA carboxylase beta chain, mitochondrial Human genes 0.000 description 1
101710152403 Prosaposin Proteins 0.000 description 1
108010076504 Protein Sorting Signals Proteins 0.000 description 1
101710157841 Protocadherin-15 Proteins 0.000 description 1
208000033522 Proximal spinal muscular atrophy type 2 Diseases 0.000 description 1
208000033550 Proximal spinal muscular atrophy type 4 Diseases 0.000 description 1
CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
238000011529 RT qPCR Methods 0.000 description 1
208000035977 Rare disease Diseases 0.000 description 1
201000008206 Renpenning syndrome Diseases 0.000 description 1
102000037054 SLC-Transporter Human genes 0.000 description 1
108091006207 SLC-Transporter Proteins 0.000 description 1
102000005041 SLC6A8 Human genes 0.000 description 1
101100533323 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) SFM1 gene Proteins 0.000 description 1
101100294206 Schizosaccharomyces pombe (strain 972 / ATCC 24843) fta4 gene Proteins 0.000 description 1
101710175903 Short-chain specific acyl-CoA dehydrogenase, mitochondrial Proteins 0.000 description 1
101710162246 Sodium- and chloride-dependent creatine transporter 1 Proteins 0.000 description 1
238000002105 Southern blotting Methods 0.000 description 1
108091081024 Start codon Proteins 0.000 description 1
208000032978 Structural Congenital Myopathies Diseases 0.000 description 1
208000003028 Stuttering Diseases 0.000 description 1
208000002903 Thalassemia Diseases 0.000 description 1
101710113296 Transcriptional regulator ATRX Proteins 0.000 description 1
206010044565 Tremor Diseases 0.000 description 1
101710091952 Tropomyosin alpha-3 chain Proteins 0.000 description 1
102000004987 Troponin T Human genes 0.000 description 1
108090001108 Troponin T Proteins 0.000 description 1
208000036142 Viral infection Diseases 0.000 description 1
108010007135 Werner Syndrome Helicase Proteins 0.000 description 1
102100035336 Werner syndrome ATP-dependent helicase Human genes 0.000 description 1
208000032460 X-linked 1 intellectual disability-hypotonic facies syndrome Diseases 0.000 description 1
208000037557 X-linked 89 intellectual disability Diseases 0.000 description 1
101000649206 Xanthomonas campestris pv. campestris (strain 8004) Uridine 5'-monophosphate transferase Proteins 0.000 description 1
201000004525 Zellweger Syndrome Diseases 0.000 description 1
101710160539 Zinc finger protein 41 Proteins 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
230000001154 acute effect Effects 0.000 description 1
230000000996 additive effect Effects 0.000 description 1
201000006960 adult spinal muscular atrophy Diseases 0.000 description 1
230000006838 adverse reaction Effects 0.000 description 1
239000003570 air Substances 0.000 description 1
239000003513 alkali Substances 0.000 description 1
125000005600 alkyl phosphonate group Chemical group 0.000 description 1
230000007815 allergy Effects 0.000 description 1
201000006288 alpha thalassemia Diseases 0.000 description 1
HXXFSFRBOHSIMQ-FPRJBGLDSA-N alpha-D-galactose 1-phosphate Chemical compound OC[C@H]1O[C@H](OP(O)(O)=O)[C@H](O)[C@@H](O)[C@H]1O HXXFSFRBOHSIMQ-FPRJBGLDSA-N 0.000 description 1
230000004075 alteration Effects 0.000 description 1
125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 description 1
BBDAGFIXKZCXAH-CCXZUQQUSA-N ancitabine Chemical compound N=C1C=CN2[C@@H]3O[C@H](CO)[C@@H](O)[C@@H]3OC2=N1 BBDAGFIXKZCXAH-CCXZUQQUSA-N 0.000 description 1
239000003098 androgen Substances 0.000 description 1
PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
KDZOASGQNOPSCU-UHFFFAOYSA-N argininosuccinate Chemical compound OC(=O)C(N)CCCN=C(N)NC(C(O)=O)CC(O)=O KDZOASGQNOPSCU-UHFFFAOYSA-N 0.000 description 1
238000011948 assay development Methods 0.000 description 1
230000037444 atrophy Effects 0.000 description 1
201000004562 autosomal dominant cerebellar ataxia Diseases 0.000 description 1
201000005768 autosomal dominant nonsyndromic deafness 3A Diseases 0.000 description 1
201000011409 autosomal recessive nonsyndromic deafness 1A Diseases 0.000 description 1
208000022362 bacterial infectious disease Diseases 0.000 description 1
230000003542 behavioural effect Effects 0.000 description 1
SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
229960003237 betaine Drugs 0.000 description 1
230000002902 bimodal effect Effects 0.000 description 1
238000002306 biochemical method Methods 0.000 description 1
239000013060 biological fluid Substances 0.000 description 1
238000001574 biopsy Methods 0.000 description 1
238000004364 calculation method Methods 0.000 description 1
150000004657 carbamic acid derivatives Chemical class 0.000 description 1
239000004202 carbamide Substances 0.000 description 1
150000004649 carbonic acid derivatives Chemical class 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
230000004640 cellular pathway Effects 0.000 description 1
230000002490 cerebral effect Effects 0.000 description 1
238000003776 cleavage reaction Methods 0.000 description 1
RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 1
239000005515 coenzyme Substances 0.000 description 1
201000011477 congenital fiber-type disproportion Diseases 0.000 description 1
230000021615 conjugation Effects 0.000 description 1
230000008602 contraction Effects 0.000 description 1
230000001276 controlling effect Effects 0.000 description 1
229960003624 creatine Drugs 0.000 description 1
239000006046 creatine Substances 0.000 description 1
108010007169 creatine transporter Proteins 0.000 description 1
231100000895 deafness Toxicity 0.000 description 1
230000000911 decarboxylating effect Effects 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
238000004925 denaturation Methods 0.000 description 1
230000036425 denaturation Effects 0.000 description 1
KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 description 1
238000011161 development Methods 0.000 description 1
BOKOVLFWCAFYHP-UHFFFAOYSA-N dihydroxy-methoxy-sulfanylidene-$l^{5}-phosphane Chemical compound COP(O)(O)=S BOKOVLFWCAFYHP-UHFFFAOYSA-N 0.000 description 1
NAGJZTKCGNOGPW-UHFFFAOYSA-K dioxido-sulfanylidene-sulfido-$l^{5}-phosphane Chemical compound [O-]P([O-])([S-])=S NAGJZTKCGNOGPW-UHFFFAOYSA-K 0.000 description 1
238000006073 displacement reaction Methods 0.000 description 1
238000001962 electrophoresis Methods 0.000 description 1
230000002996 emotional effect Effects 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
239000003623 enhancer Substances 0.000 description 1
230000001815 facial effect Effects 0.000 description 1
238000011049 filling Methods 0.000 description 1
GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
230000002538 fungal effect Effects 0.000 description 1
208000011836 galactose epimerase deficiency Diseases 0.000 description 1
238000001502 gel electrophoresis Methods 0.000 description 1
238000012268 genome sequencing Methods 0.000 description 1
238000011331 genomic analysis Methods 0.000 description 1
108060003196 globin Proteins 0.000 description 1
102000018146 globin Human genes 0.000 description 1
201000004541 glycogen storage disease I Diseases 0.000 description 1
208000011460 glycogen storage disease due to glucose-6-phosphatase deficiency type IA Diseases 0.000 description 1
238000003306 harvesting Methods 0.000 description 1
208000034737 hemoglobinopathy Diseases 0.000 description 1
238000012203 high throughput assay Methods 0.000 description 1
238000012165 high-throughput sequencing Methods 0.000 description 1
201000001082 holocarboxylase synthetase deficiency Diseases 0.000 description 1
230000000887 hydrating effect Effects 0.000 description 1
230000007062 hydrolysis Effects 0.000 description 1
125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
201000008980 hyperinsulinism Diseases 0.000 description 1
230000006872 improvement Effects 0.000 description 1
238000000126 in silico method Methods 0.000 description 1
230000002779 inactivation Effects 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
208000018337 inherited hemoglobinopathy Diseases 0.000 description 1
239000003112 inhibitor Substances 0.000 description 1
229960003786 inosine Drugs 0.000 description 1
201000006913 intermediate spinal muscular atrophy Diseases 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
208000036546 leukodystrophy Diseases 0.000 description 1
238000012417 linear regression Methods 0.000 description 1
239000007788 liquid Substances 0.000 description 1
125000001921 locked nucleotide group Chemical group 0.000 description 1
230000004777 loss-of-function mutation Effects 0.000 description 1
125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
230000002132 lysosomal effect Effects 0.000 description 1
229910001629 magnesium chloride Inorganic materials 0.000 description 1
230000008774 maternal effect Effects 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
238000011880 melting curve analysis Methods 0.000 description 1
210000004379 membrane Anatomy 0.000 description 1
239000012528 membrane Substances 0.000 description 1
230000003340 mental effect Effects 0.000 description 1
108020004999 messenger RNA Proteins 0.000 description 1
YACKEPLHDIMKIO-UHFFFAOYSA-N methylphosphonic acid Chemical compound CP(O)(O)=O YACKEPLHDIMKIO-UHFFFAOYSA-N 0.000 description 1
108091070501 miRNA Proteins 0.000 description 1
239000002679 microRNA Substances 0.000 description 1
238000002493 microarray Methods 0.000 description 1
230000003278 mimic effect Effects 0.000 description 1
210000003205 muscle Anatomy 0.000 description 1
201000000585 muscular atrophy Diseases 0.000 description 1
230000003274 myotonic effect Effects 0.000 description 1
108010054130 nebulin Proteins 0.000 description 1
238000002663 nebulization Methods 0.000 description 1
201000008084 nemaline myopathy 3 Diseases 0.000 description 1
230000003988 neural development Effects 0.000 description 1
210000002569 neuron Anatomy 0.000 description 1
208000024737 non-syndromic X-linked intellectual disability 58 Diseases 0.000 description 1
208000023864 non-syndromic X-linked intellectual disability 89 Diseases 0.000 description 1
208000023808 non-syndromic X-linked intellectual disability 90 Diseases 0.000 description 1
238000010606 normalization Methods 0.000 description 1
238000007826 nucleic acid assay Methods 0.000 description 1
239000002853 nucleic acid probe Substances 0.000 description 1
230000005257 nucleotidylation Effects 0.000 description 1
229940124276 oligodeoxyribonucleotide Drugs 0.000 description 1
238000005457 optimization Methods 0.000 description 1
125000000962 organic group Chemical group 0.000 description 1
229960003104 ornithine Drugs 0.000 description 1
201000011278 ornithine carbamoyltransferase deficiency Diseases 0.000 description 1
230000001575 pathological effect Effects 0.000 description 1
238000010647 peptide synthesis reaction Methods 0.000 description 1
239000012071 phase Substances 0.000 description 1
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
XEBWQGVWTUSTLN-UHFFFAOYSA-M phenylmercury acetate Chemical compound CC(=O)O[Hg]C1=CC=CC=C1 XEBWQGVWTUSTLN-UHFFFAOYSA-M 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
108010055837 phosphocarrier protein HPr Proteins 0.000 description 1
150000008298 phosphoramidates Chemical class 0.000 description 1
150000008300 phosphoramidites Chemical class 0.000 description 1
150000003014 phosphoric acid esters Chemical class 0.000 description 1
102000020233 phosphotransferase Human genes 0.000 description 1
108010030799 polyglutamine-binding protein 1 Proteins 0.000 description 1
238000006116 polymerization reaction Methods 0.000 description 1
230000035935 pregnancy Effects 0.000 description 1
239000002987 primer (paints) Substances 0.000 description 1
230000000750 progressive effect Effects 0.000 description 1
201000004012 propionic acidemia Diseases 0.000 description 1
MWWATHDPGQKSAR-UHFFFAOYSA-N propyne Chemical compound CC#C MWWATHDPGQKSAR-UHFFFAOYSA-N 0.000 description 1
230000004853 protein function Effects 0.000 description 1
150000003212 purines Chemical class 0.000 description 1
150000003230 pyrimidines Chemical class 0.000 description 1
238000012175 pyrosequencing Methods 0.000 description 1
208000022587 qualitative or quantitative defects of dystrophin Diseases 0.000 description 1
238000003908 quality control method Methods 0.000 description 1
102000005962 receptors Human genes 0.000 description 1
108020003175 receptors Proteins 0.000 description 1
230000009467 reduction Effects 0.000 description 1
108091008146 restriction endonucleases Proteins 0.000 description 1
238000010839 reverse transcription Methods 0.000 description 1
PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
150000003290 ribose derivatives Chemical group 0.000 description 1
238000012502 risk assessment Methods 0.000 description 1
102200087889 rs1050228 Human genes 0.000 description 1
102200054246 rs121907970 Human genes 0.000 description 1
102200128232 rs121908758 Human genes 0.000 description 1
102220010197 rs121908767 Human genes 0.000 description 1
102200125377 rs1801175 Human genes 0.000 description 1
102200054089 rs28941770 Human genes 0.000 description 1
102200054091 rs28941771 Human genes 0.000 description 1
102200054279 rs28942071 Human genes 0.000 description 1
102220181923 rs35949555 Human genes 0.000 description 1
102200128182 rs74551128 Human genes 0.000 description 1
102220002721 rs74597325 Human genes 0.000 description 1
102220002728 rs74767530 Human genes 0.000 description 1
102200128219 rs75527207 Human genes 0.000 description 1
102200132008 rs75541969 Human genes 0.000 description 1
102200128617 rs75961395 Human genes 0.000 description 1
102220002725 rs77010898 Human genes 0.000 description 1
102200128207 rs77646904 Human genes 0.000 description 1
102200128169 rs77932196 Human genes 0.000 description 1
102200128171 rs77932196 Human genes 0.000 description 1
102200128591 rs78655421 Human genes 0.000 description 1
102200132108 rs80034486 Human genes 0.000 description 1
102200128229 rs80055610 Human genes 0.000 description 1
102200128599 rs80282562 Human genes 0.000 description 1
238000005464 sample preparation method Methods 0.000 description 1
230000007017 scission Effects 0.000 description 1
238000007423 screening assay Methods 0.000 description 1
238000012772 sequence design Methods 0.000 description 1
230000019491 signal transduction Effects 0.000 description 1
239000002689 soil Substances 0.000 description 1
238000000527 sonication Methods 0.000 description 1
208000002320 spinal muscular atrophy Diseases 0.000 description 1
230000037436 splice-site mutation Effects 0.000 description 1
230000006641 stabilisation Effects 0.000 description 1
238000011105 stabilization Methods 0.000 description 1
238000007619 statistical method Methods 0.000 description 1
230000000638 stimulation Effects 0.000 description 1
230000000153 supplemental effect Effects 0.000 description 1
230000004083 survival effect Effects 0.000 description 1
208000024891 symptom Diseases 0.000 description 1
201000001850 syndromic X-linked intellectual disability Claes-Jensen type Diseases 0.000 description 1
230000002194 synthesizing effect Effects 0.000 description 1
XQTLDIFVVHJORV-UHFFFAOYSA-N tecnazene Chemical compound [O-][N+](=O)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl XQTLDIFVVHJORV-UHFFFAOYSA-N 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
150000003573 thiols Chemical class 0.000 description 1
ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 1
RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 1
ZEMGGZBWXRYJHK-UHFFFAOYSA-N thiouracil Chemical compound O=C1C=CNC(=S)N1 ZEMGGZBWXRYJHK-UHFFFAOYSA-N 0.000 description 1
229940104230 thymidine Drugs 0.000 description 1
229940113082 thymine Drugs 0.000 description 1
238000012546 transfer Methods 0.000 description 1
230000007704 transition Effects 0.000 description 1
238000011269 treatment regimen Methods 0.000 description 1
230000005751 tumor progression Effects 0.000 description 1
208000032521 type II spinal muscular atrophy Diseases 0.000 description 1
208000005606 type IV spinal muscular atrophy Diseases 0.000 description 1
238000009827 uniform distribution Methods 0.000 description 1
230000009385 viral infection Effects 0.000 description 1
230000003612 virological effect Effects 0.000 description 1
QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
239000002699 waste material Substances 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
238000012070 whole genome sequencing analysis Methods 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers

Landscapes

Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Analytical Chemistry (AREA)
Genetics & Genomics (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Microbiology (AREA)
Molecular Biology (AREA)
Physics & Mathematics (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Pathology (AREA)
Chemical Kinetics & Catalysis (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

CA2907177A 2013-03-15 2014-03-14 Procedes et compositions pour l'evaluation de marqueurs genetiques Abandoned CA2907177A1 (fr)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US201361789164P	2013-03-15	2013-03-15
US61/789,164		2013-03-15
US13/934,093 US12129514B2 (en)	2009-04-30	2013-07-02	Methods and compositions for evaluating genetic markers
US13/934,093		2013-07-02
PCT/US2014/028212 WO2014143994A2 (fr)	2013-03-15	2014-03-14	Procédés et compositions pour l'évaluation de marqueurs génétiques

Publications (1)

Publication Number	Publication Date
CA2907177A1 true CA2907177A1 (fr)	2014-09-18

Family

ID=51538293

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA2907177A Abandoned CA2907177A1 (fr)	2013-03-15	2014-03-14	Procedes et compositions pour l'evaluation de marqueurs genetiques

Country Status (3)

Country	Link
EP (1)	EP2971114A4 (fr)
CA (1)	CA2907177A1 (fr)
WO (1)	WO2014143994A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR3055338B1 (fr) *	2016-09-01	2020-05-29	Centre National De La Recherche Scientifique	Methode de detection et d'identification in vitro d'un ou plusieurs micro-organismes impliques dans le processus de degradation, de modification ou de sequestration d'un ou plusieurs contaminants presents dans un echantillon biologique
CN112029841B (zh) *	2019-06-03	2024-02-09	香港中文大学	定量端粒长度和基因组基序的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1685410A1 (fr) *	2003-11-19	2006-08-02	EVOTEC Neurosciences GmbH	Utilisation diagnostique et therapeutique du gene humain sgpl1 et d'une proteine contre les maladies neurodegeneratives
US20120165202A1 (en) *	2009-04-30	2012-06-28	Good Start Genetics, Inc.	Methods and compositions for evaluating genetic markers
AU2010242073C1 (en) *	2009-04-30	2015-12-24	Good Start Genetics, Inc.	Methods and compositions for evaluating genetic markers
US20140129201A1 (en) *	2012-11-07	2014-05-08	Good Start Genetics, Inc.	Validation of genetic tests

2014
- 2014-03-14 WO PCT/US2014/028212 patent/WO2014143994A2/fr not_active Ceased
- 2014-03-14 EP EP14762322.7A patent/EP2971114A4/fr not_active Withdrawn
- 2014-03-14 CA CA2907177A patent/CA2907177A1/fr not_active Abandoned

Also Published As

Publication number	Publication date
WO2014143994A3 (fr)	2015-02-19
EP2971114A2 (fr)	2016-01-20
EP2971114A4 (fr)	2016-11-23
WO2014143994A2 (fr)	2014-09-18

Publication	Publication Date	Title
US20240327908A1 (en)	2024-10-03	Methods and compositions for evaluating genetic markers
US12129514B2 (en)	2024-10-29	Methods and compositions for evaluating genetic markers
US20120165202A1 (en)	2012-06-28	Methods and compositions for evaluating genetic markers
Wei et al.	2011	Identification of sequence variants in genetic disease-causing genes using targeted next-generation sequencing
ES2971972T3 (es)	2024-06-10	Análisis estadístico para la determinación no invasiva de aneuploidía del cromosoma Y
EP3699292B1 (fr)	2025-01-08	Génotypage à haut rendement par séquençage de petites quantités de matériau génétique
EP2854057A2 (fr)	2015-04-01	Procédés pour une classification de ploïdie prénatale non invasive
US20050026173A1 (en)	2005-02-03	Genetic diagnosis using multiple sequence variant analysis combined with mass spectrometry
Carlson et al.	2015	MIPSTR: a method for multiplex genotyping of germline and somatic STR variation across many individuals
AU2019283856B2 (en)	2021-11-04	Non-invasive fetal sex determination
EP3649257A1 (fr)	2020-05-13	Enrichissement de régions génomiques ciblées pour analyse parallèle multiplexée
CA2907177A1 (fr)	2014-09-18	Procedes et compositions pour l'evaluation de marqueurs genetiques
Yan et al.	2022	Methyl-SNP-seq reveals dual readouts of methylome and variome at molecule resolution while enabling target enrichment
Smylie et al.	2004	Analysis of sequence variations in several human genes using phosphoramidite bond DNA fragmentation and chip-based MALDI-TOF
Helsmoortel et al.	2016	Multiplexed high resolution melting assay for versatile sample tracking in a diagnostic and research setting
Amr et al.	2015	Targeted hybrid capture for inherited disease panels
Nikolaev et al.	2009	Detection of genomic variation by selection of a 9 mb DNA region and high throughput sequencing
Gonzalez-Bosquet et al.	2010	Principles of analysis of germline genetics
Benovoy	2009	Characterization of transcript isoform variations in human and chimpanzee
Li et al.	0	Multiplex padlock targeted sequencing reveals human
Rieber	2013	Performance comparison of four human whole-genome sequencing technologies

Legal Events

Date	Code	Title	Description
2018-04-25	FZDE	Dead	Effective date: 20180314